WPWM
REGN icon

Western Pacific Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Western Pacific Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-60
Closed -$52.7K – 320
2023
Q4 		$52.7K Sell
60
-13
-18% -$10.7K 0.04% 140
2023
Q3 		$60.1K Hold
73
– – 0.05% 121
2023
Q2 		$52.5K Hold
73
– – 0.04% 138
2023
Q1 		$60K Buy
+73
New +$55.1K 0.05% 125

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Western Pacific Wealth Management's REGN Position: Q1 2024 in Review

Western Pacific Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 60 shares — an estimated $52.7K sold.

Western Pacific Wealth Management first reported a position in REGN in Q1 2023 and held it in 4 quarters. The position peaked at $60.1K in Q3 2023. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Western Pacific Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Western Pacific Wealth Management sold 60 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $52.7K.
  • Western Pacific Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • Western Pacific Wealth Management's Regeneron Pharmaceuticals position peaked at $60.1K in Q3 2023.
  • 1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Western Pacific Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.